30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

CollPlant VergenixSTR Receives CE Mark for Tendinopathy -

CollPlant received CE Mark approval for Vergenix™STR soft tissue repair matrix for the treatment of tendinopathy. EU launch is anticipated in coming months.

Initial study results released in 2015 indicated that, of ten patients in a 20-patient clinical trial of VergenixSTR, 80% of subjects reported improvement in pain and arm functionality with an increase in arm strength. Final trial results were announced in 1Q16.

Sources: CollPlant; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.